One to two million Americans have a history of systemic allergic reactions to stinging insects and must live with the knowledge that future stings could be catastrophic. Recent advances have been made in diagnosis and treatment of this problem. Pure venoms have been recognized to be superior to the whole body extract as diagnostic and treatment antigens. Use of pure venoms for immunotherapy gives far better protection than whole body extract for the allergic patient and represents a major advance in the field of allergy. The imported fire ant is very different from the other common stinging insects in its venom components, the type of local reactions caused by its sting, and the fact that whole body extract from this insect seems to be as good an antigen for diagnosis and treatment as pure venom. Although important discoveries about insect allergy have been made recently, some very important questions are yet to be answered. Among these are: (1) Can suppliers of venom provide us with enough venom to treat all patients with insect allergy? (2) How long should immunotherapy be continued? and (3) Would treatment with specific antigens from venom be superior to using whole venom? We all await the answer to these and other questions with hopeful anticipation.
有100万到200万美国人有过对螫刺昆虫产生全身性过敏反应的病史,他们必须时刻牢记,未来被蜇可能会带来灾难性后果。最近在该问题的诊断和治疗方面取得了进展。纯毒液已被认为作为诊断和治疗抗原优于全虫提取物。使用纯毒液进行免疫疗法比全虫提取物能为过敏患者提供更好的保护,这代表了过敏领域的一项重大进展。红火蚁在毒液成分、其蜇刺引起的局部反应类型以及该昆虫的全虫提取物似乎与纯毒液一样是良好的诊断和治疗抗原等方面与其他常见螫刺昆虫有很大不同。尽管最近在昆虫过敏方面有重要发现,但一些非常重要的问题仍有待解答。其中包括:(1)毒液供应商能否为我们提供足够的毒液来治疗所有昆虫过敏患者?(2)免疫疗法应持续多长时间?以及(3)用毒液中的特定抗原进行治疗是否优于使用全毒液?我们都满怀期待地等待这些以及其他问题的答案。